World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Neuroscience 98 796 716 61 57 408 44184

Brit Mollenhauer publications per year

The chart shows the history of publications by Brit Mollenhauer between 1999 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Brit Mollenhauer published across 27 years, from 1999 to 2025, averaging 17.9 papers a year. Output peaked at 41 publications in 2021. 69 of the 484 publications appeared in the last two years.

No. of publications
10 20 30 40
Bar chart. Horizontal axis: year, 1999 to 2025. Vertical axis: number of publications, 0 to 41. Peak 41 publications in 2021. 1999: 2 publications 2000: 0 publications 2001: 0 publications 2002: 4 publications 2003: 3 publications 2004: 3 publications 2005: 8 publications 2006: 9 publications 2007: 11 publications 2008: 12 publications 2009: 10 publications 2010: 8 publications 2011: 21 publications 2012: 12 publications 2013: 13 publications 2014: 13 publications 2015: 25 publications 2016: 26 publications 2017: 26 publications 2018: 25 publications 2019: 32 publications 2020: 40 publications 2021: 41 publications 2022: 32 publications 2023: 39 publications 2024: 37 publications 2025: 32 publications
1999 2025

484 publications in total across all disciplines

View publications per year as a table
Brit Mollenhauer: publications per year, 1999 to 2025
Year Publications
1999 2
2000 0
2001 0
2002 4
2003 3
2004 3
2005 8
2006 9
2007 11
2008 12
2009 10
2010 8
2011 21
2012 12
2013 13
2014 13
2015 25
2016 26
2017 26
2018 25
2019 32
2020 40
2021 41
2022 32
2023 39
2024 37
2025 32
Total 484
Download as CSV

Brit Mollenhauer publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Brit Mollenhauer sits on this spectrum.

No. of scientists
100 200 300 400 500
Bar chart with 86 bars. Horizontal axis: publications, 38–47 to 887+. Vertical axis: number of scientists, 0 to 539. Most scientists, 539, have 98–107 publications. The last bar groups every scientist with 887 publications or more. The highlighted bar, 408–417 publications, is where this scientist sits. 38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientist 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38–47 publications 887+

This scientist: 408 publications — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

View publications distribution as a table
Number of Neuroscience scientists by publication count, Research.com 2026 ranking edition. Based on 9,597 ranked scientists.
Publications Scientists This scientist
38–47 18
48–57 79
58–67 193
68–77 323
78–87 406
88–97 452
98–107 539
108–117 505
118–127 522
128–137 469
138–147 456
148–157 459
158–167 397
168–177 383
178–187 350
188–197 302
198–207 306
208–217 262
218–227 242
228–237 220
238–247 203
248–257 174
258–267 176
268–277 175
278–287 125
288–297 116
298–307 127
308–317 128
318–327 99
328–337 89
338–347 78
348–357 96
358–367 66
368–377 59
378–387 65
388–397 54
398–407 48
408–417 49 408
418–427 34
428–437 31
438–447 30
448–457 31
458–467 36
468–477 40
478–487 35
488–497 30
498–507 23
508–517 26
518–527 20
528–537 23
538–547 20
548–557 20
558–567 17
568–577 14
578–587 20
588–597 20
598–607 19
608–617 18
618–627 17
628–637 11
638–647 11
648–657 11
658–667 8
668–677 7
678–687 11
688–697 10
698–707 4
708–717 6
718–727 5
728–737 5
738–747 9
748–757 9
758–767 3
768–777 7
778–787 7
788–797 6
798–807 2
808–817 2
818–827 7
828–837 0
838–847 9
848–857 3
858–867 1
868–877 3
878–886 6
887+ 100
Download as CSV

Brit Mollenhauer D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Brit Mollenhauer sits on this spectrum.

No. of scientists
100 200 300 400 500
Bar chart with 68 bars. Horizontal axis: D-Index, 30–31 to 163+. Vertical axis: number of scientists, 0 to 512. Most scientists, 512, have 46–47 D-Index. The last bar groups every scientist with 163 D-Index or more. The highlighted bar, 98–99 D-Index, is where this scientist sits. 30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30–31 D-Index 163+

This scientist: 98 D-Index — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

View D-Index distribution as a table
Number of Neuroscience scientists by D-index, Research.com 2026 ranking edition. Based on 9,597 ranked scientists.
D-Index Scientists This scientist
30–31 42
32–33 172
34–35 296
36–37 435
38–39 459
40–41 456
42–43 467
44–45 478
46–47 512
48–49 435
50–51 425
52–53 418
54–55 392
56–57 357
58–59 334
60–61 328
62–63 260
64–65 278
66–67 239
68–69 250
70–71 210
72–73 200
74–75 189
76–77 170
78–79 146
80–81 113
82–83 126
84–85 100
86–87 84
88–89 99
90–91 84
92–93 85
94–95 72
96–97 76
98–99 45 98
100–101 49
102–103 43
104–105 32
106–107 45
108–109 50
110–111 32
112–113 39
114–115 32
116–117 29
118–119 27
120–121 19
122–123 23
124–125 27
126–127 16
128–129 24
130–131 13
132–133 21
134–135 17
136–137 14
138–139 15
140–141 10
142–143 10
144–145 13
146–147 9
148–149 8
150–151 6
152–153 6
154–155 7
156–157 7
158–159 10
160–161 4
162 8
163+ 100
Download as CSV

Overview

Brit Mollenhauer is affiliated with the University of Göttingen in Germany. Their primary field of study is Medicine, with a focus on Neurology, Physiology, Molecular Biology, Cellular and Molecular Neuroscience, and Cognitive Neuroscience.

Their research primarily covers topics related to Parkinson's Disease mechanisms and treatments, neurological disorders and treatments, Alzheimer's disease research and treatments, neurological diseases and metabolism, nuclear receptors and signaling, lysosomal storage disorders research, and RNA regulation and disease.

Frequent co-authors of Brit Mollenhauer include Claudia Trenkwalder, Friederike Sixel-Döring, Andrew Siderowf, Lana M. Chahine, and Kenneth Marek.

The scientist has published extensively in several venues, including:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • npj Parkinson s Disease
  • Movement Disorders
  • Neurology
  • Movement Disorders Clinical Practice

Notable recent papers by Brit Mollenhauer include:

  • Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study, 2023, The Lancet Neurology
  • A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research, 2024, The Lancet Neurology
  • Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium, 2020, Newcastle University ePrints (Newcastle University)
  • Trial of Prasinezumab in Early-Stage Parkinson's Disease, 2022, New England Journal of Medicine
  • Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and Safinamide, 2020, Movement Disorders Clinical Practice

Best Publications

  • Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium

    Ian G. McKeith;Bradley F. Boeve;Dennis W. DIckson;Glenda Halliday

  • Diagnostic Criteria for Mild Cognitive Impairment in Parkinson’s Disease: Movement Disorder Society Task Force Guidelines

    Irene Litvan;Jennifer G. Goldman;Alexander I. Tröster;Ben A. Schmand

  • Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria

    Günter U Höglinger;Gesine Respondek;Maria Stamelou;Carolin Kurz

  • Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity.

    Ludovico Cantuti-Castelvetri;Ludovico Cantuti-Castelvetri;Ravi Ojha;Liliana D. Pedro;Liliana D. Pedro;Minou Djannatian;Minou Djannatian

  • The Parkinson Progression Marker Initiative (PPMI)

    Kenneth Marek;Danna Jennings;Shirley Lasch;Andrew Siderowf

  • A Mutation in VPS35, Encoding a Subunit of the Retromer Complex, Causes Late-Onset Parkinson Disease

    Alexander Zimprich;Anna Benet-Pagès;Walter Struhal;Elisabeth Graf

  • Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study

    Ronald B Postuma;Alex Iranzo;Michele Hu;Birgit Högl

  • MDS Task Force on Mild Cognitive Impairment in Parkinson’s disease: Critical Review of PD-MCI

    Irene Litvan;Dag Aarsland;Charles H. Adler;Jennifer G. Goldman

  • α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study

    Brit Mollenhauer;Brit Mollenhauer;Joseph J Locascio;Walter Schulz-Schaeffer;Friederike Sixel-Döring

  • Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study

    Unknown

  • Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy

    Günter U. Höglinger;Nadine M. Melhem;Dennis W. Dickson;Patrick M A Sleiman

  • The Parkinson's progression markers initiative (PPMI): establishing a PD biomarker cohort

    Kenneth Marek;Sohini Chowdhury;Andrew Siderowf;Shirley Lasch

  • CSF and blood biomarkers for Parkinson's disease.

    Lucilla Parnetti;Lorenzo Gaetani;Paolo Eusebi;Silvia Paciotti

  • A Practical Guide to Immunoassay Method Validation

    Ulf Andreasson;Armand Perret-Liaudet;Linda J C van Waalwijk van Doorn;Kaj Blennow

  • Characterizing mild cognitive impairment in incident Parkinson disease The ICICLE-PD Study

    Alison J Yarnall;David P Breen;Gordon W Duncan;Tien K Khoo

  • Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid

    Mohammad Shahnawaz;Takahiko Tokuda;Masaaki Waragai;Nicolas Mendez

  • Trial of Prasinezumab in Early-Stage Parkinson's Disease.

    Unknown

  • Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration

    Brit Mollenhauer;Valerie Cullen;Ilana Kahn;Bryan Krastins

  • Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson’s disease and dementia with Lewy bodies

    Anne Stuendl;Marcel Kunadt;Niels Kruse;Claudia Bartels

  • Trial of Cinpanemab in Early Parkinson's Disease.

    Unknown

  • Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau181, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson Disease

    Ju-Hee Kang;Ju-Hee Kang;David J. Irwin;Alice S. Chen-Plotkin;Andrew Siderowf

  • Associated factors for REM sleep behavior disorder in Parkinson disease.

    Friederike Sixel-Döring;Ellen Trautmann;Brit Mollenhauer;Claudia Trenkwalder

  • Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update

    Marta del Campo;Brit Mollenhauer;Antonio Bertolotto;Sebastiaan Engelborghs

  • Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease.

    M. Otto;J. Wiltfang;L. Cepek;M. Neumann

  • MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity.

    Nadiya M. Teplyuk;Brit Mollenhauer;Galina Gabriely;Alf Giese

Frequent Co-Authors

Claudia Trenkwalder
Claudia Trenkwalder University of Göttingen
Jens Wiltfang
Jens Wiltfang University of Göttingen
Daniela Berg
Daniela Berg University Hospital Schleswig-Holstein
Henrik Zetterberg
Henrik Zetterberg University of Gothenburg
Wolfgang H. Oertel
Wolfgang H. Oertel Philipp University of Marburg
Ronald B. Postuma
Ronald B. Postuma McGill University
Caroline M. Tanner
Caroline M. Tanner University of California, San Francisco
Daniel Weintraub
Daniel Weintraub University of Pennsylvania
Michele T.M. Hu
Michele T.M. Hu University of Oxford
Inga Zerr
Inga Zerr University of Göttingen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in neuroscience doesn’t have to follow a traditional path. Many students interested in the brain and behavior often consider related online programs in psychology, social work, and family therapy. These fields can offer flexible pathways for those eager to enter the workforce quickly or specialize in mental health and counseling roles.

For those seeking affordability and convenience, enrolling in an online psychology degree is a popular option. Individuals hoping to transition into social work without previous experience may find 1 year msw programs online no bsw to be especially accessible and time-effective.

Advanced learners interested in clinical practice might consider earning a psyd psychology online, which focuses on hands-on therapy skills and prepares graduates for licensure. Likewise, those passionate about family and relationships might pursue one of the best online mft programs for a direct path to a career as a marriage and family therapist.

Each of these online degrees offers unique opportunities and career outcomes that complement a background—or interest—in neuroscience.

Best Scientists Citing Brit Mollenhauer

Trending Scientists

Recently Published Articles